China Meheco Group Co.,Ltd.(600056),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

600056 China Meheco Group Co.,Ltd.

Closed 12-19 15:00:00

10.63

-0.03

-0.28%

High10.70	Low10.56	Vol11.23M
Open10.62	D1 Closing10.66	Amplitude1.31%
Mkt Cap15.90B	Tradable Cap15.89B	Total Shares1.50B
T/O119.00M	T/O Rate0.75%	Tradable Shares1.50B
P/B1.34	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"600056","market":"SH","secType":"STK","nameCN":"China Meheco Group Co.,Ltd.","latestPrice":10.63,"timestamp":1766127601000,"preClose":10.66,"halted":0,"volume":11229100,"delay":0,"changeRate":-0.0028,"floatShares":1495000000,"shares":1496000000,"eps":0.3631,"marketStatus":"Closed","change":-0.03,"latestTime":"12-19 15:00:00","open":10.62,"high":10.7,"low":10.56,"amount":119000000,"amplitude":0.0131,"askPrice":10.63,"askSize":559,"bidPrice":10.62,"bidSize":2257,"shortable":0,"etf":0,"ttmEps":0.3631,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766367000000},"marketStatusCode":5,"adr":0,"adjPreClose":10.66,"symbolType":"stock","openAndCloseTimeList":[[1766107800000,1766115000000],[1766120400000,1766127600000]],"highLimit":11.73,"lowLimit":9.59,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1495879748,"isCdr":false,"pbRate":1.34,"roa":"--","peRate":29.275682,"roe":"3.72%","epsLYR":0.358,"committee":0.155856,"marketValue":15901000000,"turnoverRate":0.0075,"status":1,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-12-22.","floatMarketCap":15896000000},"requestUrl":"/m/hq/s/600056/tweets","defaultTab":"tweets","newsList":[{"id":"1112154589","title":"BOCOM INTL: China's 1st-8th Batch National Drug Procurement Renewal Rules Likely Moderate, Short-Term Catalysts Ample","url":"https://stock-news.laohu8.com/highlight/detail?id=1112154589","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112154589?lang=en_us&edition=fundamental","pubTime":"2025-12-05 10:48","pubTimestamp":1764902897,"startTime":"0","endTime":"0","summary":"The Hang Seng Healthcare Index rose 0.5% this week, underperforming the broader market. Biopharmaceuticals, prescription drugs, and medical equipment sectors outperformed others. Domestic investors...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","06996","600056","BK0082","02096","BK1161","BK1147","BK0010","BK1191","BK0250","01530","BK1587","BK0175","BK1583","BK1588","BK1593","BK0188","LU2488822045.USD","02268","BK1141","BK1574","SG9999014674.SGD","00013","BK0028","HK0000165453.HKD","03329"],"gpt_icon":0},{"id":"1188476394","title":"China Meheco Group (600056.SH): Ganciclovir for Injection Passes Generic Drug Consistency Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=1188476394","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188476394?lang=en_us&edition=fundamental","pubTime":"2025-11-21 18:51","pubTimestamp":1763722261,"startTime":"0","endTime":"0","summary":"China Meheco Group Co.,Ltd. (600056.SH) announced that its wholly-owned subsidiary, Hainan General Kangli Pharmaceutical Co., Ltd. (\"Kangli Pharma\"), recently received two \"Drug Supplement Approval...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0082","BK0185","BK0028","BK0010","600056","BK0250","BK0175"],"gpt_icon":0},{"id":"1100971359","title":"China Meheco Group Reports 139,689 Shareholders as of September 30, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1100971359","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100971359?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:10","pubTimestamp":1763647848,"startTime":"0","endTime":"0","summary":"China Meheco Group Co., Ltd. (600056) announced on November 20 that its total number of shareholders reached 139,689 as of September 30, 2025. The disclosure was made in response to investor inquiries on the company's interactive platform.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK0010","BK0250","BK0028","BK0175","BK0082","600056","BK0188"],"gpt_icon":0},{"id":"1147659499","title":"CITIC Securities: Chinese Pharma Firms Actively Explore Diversified Global Expansion, Focusing on New Growth and Industry M&A","url":"https://stock-news.laohu8.com/highlight/detail?id=1147659499","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147659499?lang=en_us&edition=fundamental","pubTime":"2025-11-20 12:36","pubTimestamp":1763613385,"startTime":"0","endTime":"0","summary":"Chinese pharmaceutical companies are entering a critical phase of \"innovation realization + global expansion,\" supported by demographic advantages, domestic demand, and full industrial chain...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","BK0276","BK0028","BK0188","BK0082","BK0185","BK0010","600056","BK0175","601066"],"gpt_icon":0},{"id":"1136037795","title":"Golden Eagle Fund: China's Pharmaceutical Industry Upgrade Continues, Focus on Three Investment Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=1136037795","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136037795?lang=en_us&edition=fundamental","pubTime":"2025-11-19 11:00","pubTimestamp":1763521232,"startTime":"0","endTime":"0","summary":"Pharmaceutical listed companies have completed their Q3 2025 earnings disclosures, with the sector's overall revenue growing 0.20% year-over-year. Structurally, the industry remains...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0082","BK0185","BK0175","600056","BK0028","BK0250","BK0010","BK0188"],"gpt_icon":0},{"id":"1179668786","title":"Guo Guangchang: Original Innovation is the Inevitable Path for China's Pharmaceutical Industry, Open Collaboration is the Best Way to Accelerate Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=1179668786","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179668786?lang=en_us&edition=fundamental","pubTime":"2025-11-08 19:51","pubTimestamp":1762602665,"startTime":"0","endTime":"0","summary":"Today, it is a great pleasure to gather with old and new friends in Shanghai for the 3rd Pujiang Biopharmaceutical Original Innovation Conference. Shanghai is not only a key hub for Fosun’s...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600056","BK0185","BK0250","BK0082","BK0010","BK0175","BK1230","BK0188","00656","BK0028"],"gpt_icon":0},{"id":"1146763761","title":"China Meheco Group Upgraded to 'A' Rating in ESG Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1146763761","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146763761?lang=en_us&edition=fundamental","pubTime":"2025-11-05 20:10","pubTimestamp":1762344640,"startTime":"0","endTime":"0","summary":"China Meheco Group Co., Ltd. announced on November 5 that its ESG (Environmental, Social, and Governance) rating has been upgraded to 'A' by Wind's 2025 ESG assessment. The upgrade reflects the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","600056","BK0185","BK0175","BK0010","BK0082","BK0028","BK0250"],"gpt_icon":0},{"id":"1138883768","title":"Breakthrough Record: China Medical's Largest Offshore Deal Exceeds 80 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1138883768","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138883768?lang=en_us&edition=fundamental","pubTime":"2025-10-25 16:51","pubTimestamp":1761382260,"startTime":"0","endTime":"0","summary":"The recent deal between China Meheco Group Co., Ltd. and Takeda Pharmaceutical has set a new record in the history of China's offshore pharmaceutical transactions, totaling an impressive $11.4...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK0028","BK0082","600056","BK0250","BK0175","BK0188","BK0010"],"gpt_icon":0},{"id":"2577358935","title":"China Approves Meheco Supplementary Application for Vitamin B6 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2577358935","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577358935?lang=en_us&edition=fundamental","pubTime":"2025-10-22 15:09","pubTimestamp":1761116996,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration approved Meheco's  supplementary application for its vitamin B6 injection, according to a Wednesday filing with the Shanghai bourse.The vitamin B6 injection could be used as a supplement for pregnant women and can treat radiation sickness, vomiting following chemotherapy, seborrheic dermatitis, and isoniazid or tuberculosis drug poisoning, the filing said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0175","BK0188","BK0010","600056","BK0185","BK0250","BK0082","BK0028"],"gpt_icon":0},{"id":"1125233565","title":"Yonyou Network (600588) Wins Procurement Project from China Meheco Group Co., Ltd. with a Bid Amount of 4.3 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1125233565","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125233565?lang=en_us&edition=fundamental","pubTime":"2025-10-20 18:51","pubTimestamp":1760957477,"startTime":"0","endTime":"0","summary":"According to data from Qichacha, as per the announcement on October 20, 2025, Yonyou Network Technology Co., Ltd. has won the procurement project from China Meheco Group Co., Ltd., with a bid amount...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","BK0032","BK0142","LU1064130708.USD","LU1064131003.USD","BK0231","BK0018","BK0038","600056","BK0012","BK0082","LU2148510915.USD","BK0039","BK0196","BK0175","BK0010","BK0030","BK0185","BK0188","600588","BK0028","BK0079"],"gpt_icon":0},{"id":"1175881971","title":"IPO News | Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) Pursues Hong Kong Stock Exchange Listing, Maintains 8-Year Streak on \"China's Top 100 Pharmaceutical Companies\" List","url":"https://stock-news.laohu8.com/highlight/detail?id=1175881971","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175881971?lang=en_us&edition=fundamental","pubTime":"2025-09-29 14:50","pubTimestamp":1759128645,"startTime":"0","endTime":"0","summary":"According to disclosures from the Hong Kong Stock Exchange on September 29, Changchun High-Tech Industry (Group) Co.,Ltd. (referred to as Changchun High-Tech Industry (Group) Co.,Ltd.) has submitted...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0075","600056","BK0046","BK0188","BK0239","BK0175","BK0028","BK0250","000661","BK0010","BK0057","BK0082","BK0185","HEXmain"],"gpt_icon":0},{"id":"1167469646","title":"BOCOM International: Trump's Drug Tariffs Have Limited Impact on Chinese Pharmaceuticals, Recommends Focus on AKESO (09926) and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=1167469646","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167469646?lang=en_us&edition=fundamental","pubTime":"2025-09-29 11:50","pubTimestamp":1759117844,"startTime":"0","endTime":"0","summary":"BOCOM International released a research report stating that Trump announced a 100% tariff on all branded/patented drugs starting in October, unless the manufacturer is constructing production...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348766576.USD","LU0417516902.SGD","09926","BK0185","BK0175","IE00B5MMRT66.SGD","LU0348767384.USD","LU0417516571.SGD","BK1161","BK0028","BK1583","LU0634319403.HKD","BK0010","02096","LU0196878994.USD","LU2476274308.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU0348825331.USD","LU0348783233.USD","LU1969619763.USD","LU1794554557.SGD","LU0561508036.HKD","LU1961090484.USD","BK1147","BK0250","IE00BPRC5H50.USD","600056","BK0188","LU2399975544.HKD","LU2476274720.SGD","LU2488822045.USD","LU1720050803.USD","LU2328871848.SGD","06990","LU2778985437.USD","06996","BK0082","09995","BK1191","BK1593","BK1574","LU0348784397.USD","LU0348735423.USD","LU0348827113.USD","LU0417516738.SGD","03329","01530"],"gpt_icon":0},{"id":"2569727456","title":"China Meheco's Unit Gets Nod for Supplementary Application for Lincomycin Hydrochloride Injection After Passing Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2569727456","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569727456?lang=en_us&edition=fundamental","pubTime":"2025-09-24 13:59","pubTimestamp":1758693554,"startTime":"0","endTime":"0","summary":"China Meheco Group's  unit, Tianfang Pharmaceutical, received approval from the Chinese drug administrator for its drug supplementary application for lincomycin hydrochloride injection after the drug passed regulatory evaluation, according to a Shanghai bourse filing on Wednesday.The drug, which is mainly used for the treatment of severe infections caused by susceptible strains such as streptococci, pneumococci, and staphylococci, was tested for its consistency in quality and efficiency.The Chinese drugmaker's shares dropped less than 2% during the afternoon trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0175","BK0185","BK0010","BK0250","BK0028","600056","BK0082","BK0188"],"gpt_icon":0},{"id":"1154383120","title":"China Meheco Group's Subsidiary Receives Approval for Lincomycin Hydrochloride Injection Generic Drug Consistency Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=1154383120","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154383120?lang=en_us&edition=fundamental","pubTime":"2025-09-23 16:14","pubTimestamp":1758615264,"startTime":"0","endTime":"0","summary":"China Meheco Group Co.,Ltd. (600056.SH) announced that its wholly-owned subsidiary, Tianfang Pharmaceutical Co., Ltd., has recently received the \"Drug Supplementary Application Approval Notice\" for...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK0028","BK0082","600056","BK0250","BK0175","BK0188","BK0010"],"gpt_icon":0},{"id":"1159163364","title":"Medical E-commerce Concept Stocks Surge in Afternoon Trading, China Meheco Group Hits Daily Limit Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1159163364","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159163364?lang=en_us&edition=fundamental","pubTime":"2025-09-18 14:10","pubTimestamp":1758175842,"startTime":"0","endTime":"0","summary":"On September 18th, medical e-commerce concept stocks experienced a sharp rally during afternoon trading. China Meheco Group Co.,Ltd. surged to hit the daily limit up, while Shuyu Pingmin, Zhendong Pharmaceutical, Laobaixing Pharmacy, and Liuyao Group also posted significant gains in sympathy.\n","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","600056","BK0185","BK0175","BK0010","BK0082","BK0028","BK0250"],"gpt_icon":0},{"id":"1141902117","title":"Jin Ying Fund's Ouyang Juan: China's Pharmaceutical Industry Upgrade Continues to Deliver, Focus on Innovative Drugs and Supply Chain","url":"https://stock-news.laohu8.com/highlight/detail?id=1141902117","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141902117?lang=en_us&edition=fundamental","pubTime":"2025-09-09 10:20","pubTimestamp":1757384446,"startTime":"0","endTime":"0","summary":"Pharmaceutical listed companies have completed their mid-2025 interim performance disclosures. Overall, the pharmaceutical industry's total sector revenue declined 3.06% year-over-year in the first...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK0082","BK1161","600056","BK1574","BK0250","159992","BK0185","BK0010","BK0188","BK0028","BK0175"],"gpt_icon":0},{"id":"1152030014","title":"China Merchants International: Chinese Pharmaceutical Stocks Expected to Continue Rising on Innovation Drug Overseas Expansion and Domestic Policy Optimization, Recommends Buying 3SBIO (01530) and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=1152030014","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152030014?lang=en_us&edition=fundamental","pubTime":"2025-09-08 14:36","pubTimestamp":1757313378,"startTime":"0","endTime":"0","summary":"China Merchants International released a research report stating that the Chinese pharmaceutical industry is expected to continue its upward trajectory, benefiting from positive factors including...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","BK0175","LU2097828714.EUR","02268","LU2097828631.EUR","LU2097828805.USD","BK0185","BK0010","SG9999014674.SGD","BK0250","LU2097828557.USD","BK1574","LU0455707207.USD","BK1593","600056","IE00BZ08YT58.USD","SG9999004311.SGD","LU2097828474.EUR","BK0082","01530","159992","LU2328871848.SGD","BK1191","BK1141","BK1207","BK1589","BK1219","01801","01177","BK1161","BK1521","LU2242644610.SGD","LU2488822045.USD","IE00BZ08YS42.EUR","02273","LU0502904849.HKD","BK0028","BK1515","LU1969619763.USD","02367","BK0188","06978","BK1583"],"gpt_icon":1},{"id":"1158182979","title":"China's Medical Device Import and Export Totaled $41.09 Billion in H1 2025, Up 1.1% YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=1158182979","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158182979?lang=en_us&edition=fundamental","pubTime":"2025-08-20 17:08","pubTimestamp":1755680880,"startTime":"0","endTime":"0","summary":"According to statistics from the China Chamber of Commerce for Import and Export of Medicines and Health Products, China's medical device import and export volume reached $41.09 billion in the first...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK1222","BK0010","BK0250","BK1574","BK0028","09997","BK1100","159883","BK0175","BK0082","600056","BK1583","09996","BK0188"],"gpt_icon":0},{"id":"1105597119","title":"Chinese Pharmaceuticals Ascend Global Stage! In This Value Revaluation Era, Who Will Dominate Investment Heights?","url":"https://stock-news.laohu8.com/highlight/detail?id=1105597119","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105597119?lang=en_us&edition=fundamental","pubTime":"2025-08-19 12:33","pubTimestamp":1755578006,"startTime":"0","endTime":"0","summary":"The ascendancy of Chinese pharmaceuticals on the global stage, combined with professional stewardship that deeply understands industry dynamics, may be the key to commanding this fertile investment...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK0028","BK0082","600056","BK0250","BK0175","BK0188","BK0010"],"gpt_icon":0},{"id":"1187058234","title":"CCB International Maintains Cautious Optimism on Chinese Pharmaceutical Stocks Despite High Valuations, Assigns \"Outperform\" Rating to BeiGene (06160)","url":"https://stock-news.laohu8.com/highlight/detail?id=1187058234","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187058234?lang=en_us&edition=fundamental","pubTime":"2025-08-14 17:38","pubTimestamp":1755164281,"startTime":"0","endTime":"0","summary":"CCB International released a research report maintaining a cautiously optimistic stance on China's pharmaceutical industry. The firm noted that since early 2025, Hong Kong biotech stocks have risen...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","ONC","LU0588546209.SGD","LU0307460666.USD","LU1969619763.USD","688235","BK4139","BK0082","600056","06160","BK4526","BK1588","BK1500","BK0239","BK1161","BK1583","LU2328871848.SGD","BK0175","BK0250","BK0028","BK4585","BK0188","BK0010"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-05-15","address":"北京市丰台区西营街1号院1区1号楼25-28层","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0441},{"period":"3month","weight":-0.0781},{"period":"6month","weight":0.0504},{"period":"1year","weight":-0.0785},{"period":"ytd","weight":-0.0328}],"companyName":"中国医药健康产业股份有限公司","boardCode":"AI0051","perCapita":"10704股","boardName":"批发业","registeredCapital":"149587万元","compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":-0.0143},{"period":"3month","weight":0.0184},{"period":"6month","weight":0.1579},{"period":"1year","weight":0.1544},{"period":"ytd","weight":0.1607}],"survey":"　　中国医药健康产业股份有限公司的主营业务是医药领域的生产、加工和贸易。公司的主要产品是医药商业、医疗器械、国际贸易。公司入选药智网“2025中国化药研发实力排行榜TOP100”第50位；入选第七届CMC-CHINA中国制药工业博览会“2025中国制药工业TOP101”第87位。","serverTime":1766258202112,"listedPrice":7.02,"stockholders":"139689人(较上一季度增加0.69%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"China Meheco Group Co.,Ltd.(600056),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest China Meheco Group Co.,Ltd.(600056) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"China Meheco Group Co.,Ltd.,600056,China Meheco Group Co.,Ltd.股票,China Meheco Group Co.,Ltd.股票老虎,China Meheco Group Co.,Ltd.股票老虎国际,China Meheco Group Co.,Ltd.行情,China Meheco Group Co.,Ltd.股票行情,China Meheco Group Co.,Ltd.股价,China Meheco Group Co.,Ltd.股市,China Meheco Group Co.,Ltd.股票价格,China Meheco Group Co.,Ltd.股票交易,China Meheco Group Co.,Ltd.股票购买,China Meheco Group Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"China Meheco Group Co.,Ltd.(600056),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest China Meheco Group Co.,Ltd.(600056) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction